Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Shares Issued (2016 - 2025)

Macrogenics (MGNX) has disclosed Shares Issued for 14 consecutive years, with $63000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 101.92% to $63000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $129000.0, a N/A change, with the full-year FY2025 number at $129000.0, changed N/A from a year prior.
  • Shares Issued was $63000.0 for Q4 2025 at Macrogenics, down from $66000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.6 million in Q1 2024 to a low of -$3.3 million in Q4 2024.
  • A 5-year average of $388437.5 and a median of $267000.0 in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 2507.14% in 2023, then skyrocketed 328.41% in 2024.
  • Macrogenics' Shares Issued stood at -$763000.0 in 2021, then surged by 134.08% to $260000.0 in 2022, then grew by 5.38% to $274000.0 in 2023, then tumbled by 1295.62% to -$3.3 million in 2024, then skyrocketed by 101.92% to $63000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Shares Issued are $63000.0 (Q4 2025), $66000.0 (Q2 2025), and -$3.3 million (Q4 2024).